Digital Twins in Healthcare Market

The report "Digital Twins in Healthcare Market By Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2031" The digital twins in healthcare market is expected to reach USD 101.19 billion by 2031 from USD 7.47 billion in 2026, at a CAGR of 68.4%.

Browse 110 market data Tables and 40 Figures spread through 180 Pages and in-depth TOC on "Digital Twins in Healthcare Market By Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/digital-twins-in-healthcare-market-74014375.html

Market growth is spurred by the increased application of digital twins within the healthcare industry. Digital twins are gaining widespread acceptance owing to the several benefits that they provide. The use of digital twins is likely to transform precision medicine through their ability to facilitate accurate diagnosis, personalized treatment, and effective treatment of patients. They help collect patient data such as their physiological and genetic information, medical records, lifestyle and even the environment surrounding the patient. Additionally, they have the capacity to simulate specific body organs, individual cells or the genetic makeup of an individual, among other physiological information.

The body part twins segment is expected to register the fastest growth in the digital twins in healthcare market during the forecast period.

Based on the type, the market for digital twins in healthcare has been divided into process twins, system twins, whole body twins, and body part twins, with the body part twins segment expected to witness the highest growth rate in the forecast period. Such a tendency can be explained by an increasing number of cases when digital models for certain organs are applied in clinical practice. Unlike whole-body digital models, organ models are much simpler and thus easier to implement in medical practice and to validate. They can be used for personalized medicine applications to help plan treatment, simulate surgery and assess how diseases progress. Moreover, recent developments prove that such a trend is likely to become even stronger. Namely, there has been an example when digital twin models of certain organs, such as the esophagus and heart, have been used in hospitals to simulate the results of surgical intervention. In addition, a wider application of AI, IoT, and real-time data in medicine means that the development of organ models becomes faster and more efficient than the development of whole body models.

By end user, the healthcare providers segment accounted for the largest share of the digital twins in healthcare market.

Based on end users, the digital twins in healthcare market is segmented into pharma & biopharma companies, research & academia, healthcare providers, medical device companies, and other end users (payers, diagnostic labs, patients, and CROs). Healthcare providers accounted for the largest share of the digital twins in healthcare market in 2025. This high growth is attributed to the improved diagnostic ability in hospitals, increased adoption of telemedicine & telehealth in the healthcare industry, and increasing digital twin adoption in the healthcare industry. Also, digital twins will help to plan and design hospitals by modeling different floor plans, layout plans, and workflows. 

North America registered the largest share in the global digital twins in healthcare market in 2025.

The region’s leadership in this area is mainly characterized by the prevalence of the adoption of advanced digital technologies, well-developed infrastructure for healthcare information technology, and active involvement in clinical research. The leading country here is the US due to increased adoption of AI technologies, real-world data, and simulation in both clinical practice and research. Besides, the contribution to the spread of digital twins has been made by the US Food and Drug Administration, which promotes the use of modeling and simulation technologies in drug development. Another reason why the US occupies the leading position in terms of adoption of digital twin technologies is that there are many reputable healthcare organizations and clinics, such as Mayo Clinic and Massachusetts General Hospital, conducting clinical studies focused on the application of AI and data analysis for personalized medicine. Finally, digital twin solutions have become more advanced thanks to technology developers such as Microsoft Corporation and GE HealthCare, who develop digital twin technology based on cloud technology and advanced imaging systems.

Microsoft Corporation (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Amazon Web Services, Inc. (US), Dassault Systèmes (France), GE Healthcare (US), IBM (US), NVIDIA Corporation (US), Oracle Corporation (US), PTC (US), SAP (Germany), Atos SE (France), ANSYS, Inc. (US), Faststream Technologies (US), Rescale, Inc. (US), Twin Health (US), NUREA (France), Predictiv (US), Verto (Canada), Qbio (US), Virtonomy GmbH (Germany), Unlearn.ai, Inc. (US), ThoughtWire (Canada), Sim and Cure (France), and PrediSurge (France).

Don’t miss out on business opportunities in Digital Twins in Healthcare Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/